XTX Topco’s Aurinia Pharmaceuticals AUPH Stock Holding History

XTX Topco’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.63M	Buy	+177,381	New	+$2.59M	0.05%	646
2025 Q4	–	Sell	-21,686	Closed	-$240K	–	3313
2025 Q3	$240K	Buy	+21,686	New	+$237K	0.01%	1693
2025 Q2	–	Sell	-106,435	Closed	-$856K	–	2345
2025 Q1	$856K	Buy	106,435 +63,681	+149%	+$516K	0.04%	657
2024 Q4	$384K	Buy	+42,754	New	+$349K	0.03%	1003
2024 Q2	–	Sell	-23,491	Closed	-$118K	–	1856
2024 Q1	$118K	Buy	+23,491	New	+$159K	0.02%	1332
2023 Q4	–	Sell	-24,261	Closed	-$189K	–	1578
2023 Q3	$189K	Buy	24,261 +10,700	+79%	+$105K	0.03%	1033
2023 Q2	$131K	Buy	+13,561	New	+$141K	0.02%	1119
2023 Q1	–	Sell	-68,543	Closed	-$296K	–	1265
2022 Q4	$296K	Buy	68,543 +35,790	+109%	+$208K	0.06%	592
2022 Q3	$246K	Buy	32,753 +19,502	+147%	+$169K	0.06%	634
2022 Q2	$133K	Buy	+13,251	New	+$148K	0.05%	573

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

XTX Topco's AUPH Position: Q1 2026 in Review

XTX Topco opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 177,381 shares worth $2.63M. The stake represents 0.05% of the portfolio and ranks #646 among its holdings. This is a return to the name: XTX Topco previously reported a position in AUPH as recently as Q3 2025.

XTX Topco first reported a position in AUPH in Q2 2022 and has held it in 10 quarters since. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

XTX Topco held 177,381 shares of Aurinia Pharmaceuticals worth $2.63M as of Q1 2026.
Aurinia Pharmaceuticals was a new XTX Topco position in Q1 2026.
Aurinia Pharmaceuticals made up 0.05% of XTX Topco's portfolio in Q1 2026, its #646 holding.
XTX Topco first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 10 quarters since.
259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.